Institute of Metabolism and Systems Research, Tommy's National Centre for Miscarriage Research, University of Birmingham, Birmingham, UK.
CARE Fertility Birmingham, Birmingham, UK.
Ultrasound Obstet Gynecol. 2023 Jul;62(1):23-41. doi: 10.1002/uog.26159. Epub 2023 Apr 28.
To determine the prevalence of adenomyosis in women with subfertility.
A systematic search was conducted in MEDLINE, EMBASE, CINAHL Plus, Google Scholar, PsycINFO and Web of Science Core Collection from database inception to October 2022. The included studies evaluated the prevalence of adenomyosis in women with subfertility, with or without endometriosis and/or uterine fibroids. Secondary analyses were conducted to identify variation in the prevalence of isolated adenomyosis according to geographical location, diagnostic modality, diagnostic criteria, type of ultrasound, ultrasound features of adenomyosis and the use of assisted reproductive technology.
Among 21 longitudinal studies evaluating 25 600 women, the overall pooled prevalence of isolated adenomyosis was 10% (95% CI, 6-15%) (I = 99.1%; tau = 0.12). The pooled prevalence was 1% (95% CI, 0-4%) for adenomyosis with concurrent fibroids (eight studies; I = 95.8%; tau = 0.03), 6% (95% CI, 3-11%) for adenomyosis with concurrent endometriosis (18 studies; I = 98.6%; tau = 0.12) and 7% (95% CI, 2-13%) for adenomyosis with concurrent endometriosis and/or fibroids (nine studies; I = 98.3%; tau = 0.09). The prevalence of isolated adenomyosis varied substantially according to geographical location, with Australia exhibiting the highest pooled prevalence of adenomyosis (19% (95% CI, 12-27%)), which was significantly higher compared with that in Asia (5% (95% CI, 1-12%)). The pooled prevalence of isolated adenomyosis diagnosed using a combination of direct and indirect ultrasound features was 11% (95% CI, 7-16%), whereas it was 0.45% (95% CI, 0-1%) in the study in which only an indirect feature was used as the diagnostic criterion.
One in 10 women with subfertility have a diagnosis of isolated adenomyosis. The prevalence of adenomyosis varies according to the presence of concurrent endometriosis and/or fibroids. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
确定不孕女性中腺肌病的患病率。
系统检索 MEDLINE、EMBASE、CINAHL Plus、Google Scholar、PsycINFO 和 Web of Science Core Collection 自数据库建立以来至 2022 年 10 月的文献。纳入的研究评估了不孕女性中腺肌病的患病率,包括有无子宫内膜异位症和/或子宫肌瘤。进行了二次分析,以根据地理位置、诊断方式、诊断标准、超声类型、腺肌病的超声特征和辅助生殖技术的使用情况,确定孤立性腺肌病患病率的差异。
在 21 项评估 25600 名女性的纵向研究中,孤立性腺肌病的总合并患病率为 10%(95%CI,6-15%)(I²=99.1%;tau²=0.12)。腺肌病合并子宫肌瘤的患病率为 1%(95%CI,0-4%)(8 项研究;I²=95.8%;tau²=0.03),腺肌病合并子宫内膜异位症的患病率为 6%(95%CI,3-11%)(18 项研究;I²=98.6%;tau²=0.12),腺肌病合并子宫内膜异位症和/或子宫肌瘤的患病率为 7%(95%CI,2-13%)(9 项研究;I²=98.3%;tau²=0.09)。根据地理位置的不同,孤立性腺肌病的患病率差异很大,澳大利亚的腺肌病患病率最高(19%(95%CI,12-27%)),明显高于亚洲(5%(95%CI,1-12%))。使用直接和间接超声特征相结合诊断的孤立性腺肌病的合并患病率为 11%(95%CI,7-16%),而仅使用间接特征作为诊断标准的研究中的患病率为 0.45%(95%CI,0-1%)。
每 10 名不孕女性中就有 1 名被诊断为孤立性腺肌病。腺肌病的患病率因同时存在子宫内膜异位症和/或子宫肌瘤而有所不同。© 2023 约翰威立父子公司出版公司。超声在妇产科由国际妇产科超声学会代表出版。